Breaking News Instant updates and real-time market news.

ITCI

Intra-Cellular

$9.63

0.41 (4.45%)

15:45
11/26/19
11/26
15:45
11/26/19
15:45

Intra Cellular Therapies call volume above normal and directionally bullish

Bullish option flow detected in Intra Cellular Therapies with 2,517 calls trading, 1.6x expected, and implied vol increasing over 55 points to 290.83%. Dec-19 5 puts and Dec-19 12.5 calls are the most active options, with total volume in those strikes near 1,400 contracts. The Put/Call Ratio is 0.66. Earnings are expected on February 26th.

  • 27

    Dec

ITCI Intra-Cellular
$9.63

0.41 (4.45%)

09/10/19
CANT
09/10/19
NO CHANGE
Target $27
CANT
Overweight
Intra-Cellular data turnaround time bodes well for PDUFA, says Cantor Fitzgerald
After Intra-Cellular Therapies announced it has provided the additional non-clinical toxicology data that the FDA requested, Cantor Fitzgerald analyst Charles Duncan says the "rapid" turnaround bodes well for the December 27 action date. Further, the analyst believes the FDA's current plans to not hold a panel meeting reflects the submission of a "robust" new drug application data package and lack of panel-worthy discussion points. He views view the second half of 2019 and early 2020 as "transformational" for Intra-Cellular and keeps an Overweight rating on the shares with a $27 price target.
09/10/19
LEER
09/10/19
NO CHANGE
LEER
Outperform
SVB Leerink says no AdCom 'probably good news' for Intra-Cellular
SVB Leerink analyst Marc Goodman reiterated an Outperform rating on Intra-Cellular after the FDA said it does not have plans to schedule an Advisory Committee, or AdCom, meeting in connection with its review of the company's New Drug Application for lumateperone for the treatment of schizophrenia. In a research note to investors, Goodman says that while he is "surprised" at the FDA's move, he notes that the FDA "has not been doing AdComs like they used to, and this product may fit into that new paradigm," and believes no AdCom is "probably good news." Goodman also notes that some investors have expressed concern with the efficacy data because of prior failed studies for Luma, but feels the FDA understands that this is a part of drug development in the category.
09/10/19
JPMS
09/10/19
NO CHANGE
Target $20
JPMS
Overweight
Intra-Cellular slide surprising following lumateperone update, says JPMorgan
JPMorgan analyst Jessica Fye said she is surprised that shares of Intra-Cellular are lower following the announcement that the FDA does not plan to schedule an Advisory Committee meeting to discuss lumateperone for schizophrenia. She thinks the base-case interpretation of the ad com update is positive, as it potentially is a sign of the FDA's comfort with lumateperone's risk/benefit and suggests the agency is comfortable evaluating the drug without outside feedback. The analyst, who added that management characterized their FDA dialogue as "very constructive" and said that they feel positive about the ad com update, is incrementally positive on the likelihood of approval following the update and keeps an Overweight rating on Intra-Cellular shares.
09/10/19
JMPS
09/10/19
NO CHANGE
Target $21
JMPS
Outperform
JMP Securities sees 'successful' review of Intra-Cellular lumateperone NDA
JMP Securities analyst Jason Butler reiterated an Outperform rating and $21 price target on Intra-Cellular following the announcement that the FDA does not plan to schedule an Advisory Committee meeting to discuss lumateperone for schizophrenia. In a research note to investors, Butler says he remains confident that the company has adequately addressed the FDA's questions and maintains his expectation for a "successful" NDA review and approval of lumateperone by the PDUFA date.

TODAY'S FREE FLY STORIES

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Retail Sales less autos to be reported at 08:30 »

November Retail Sales…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

EA

Electronic Arts

$105.08

1.9 (1.84%)

, ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$105.08

1.9 (1.84%)

ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

GME

GameStop

$5.58

0.05 (0.90%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$125.33

2.95 (2.41%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Retail Sales to be reported at 08:30 »

November Retail Sales…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Business Inventories to be reported at 10:00 »

October Business…

TTWO

Take-Two

$125.33

2.95 (2.41%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Take-Two management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

HY

Hyster-Yale Materials

$64.70

1.14 (1.79%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Hyster-Yale Materials management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 26

    Feb

OGI

Organigram

$2.57

(0.00%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Organigram management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
BTIG biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

Week of 12/13…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
JPMorgan oil services/equip analyst to hold an analyst/industry conference call »

Oil Services &…

RPT

Ramco-Gershenson

$14.52

-0.2 (-1.36%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Ramco-Gershenson management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 20

    Feb

COO

Cooper Companies

$314.43

7.7 (2.51%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Cooper Companies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
JPMorgan media analyst to hold an analyst/industry conference call »

Media Analyst Quadrani…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
UBS services analysts to hold an analyst/industry conference call »

Services Analysts Geiger…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

Week of 12/13…

YEXT

Yext

$14.02

-0.005 (-0.04%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Yext management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

DLB

Dolby

$68.17

0.81 (1.20%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Dolby management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AOBC

American Outdoor Brands

$9.27

0.12 (1.31%)

, AVCO

Avalon GloboCare

$2.33

0.23 (10.95%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.27

0.12 (1.31%)

AVCO

Avalon GloboCare

$2.33

0.23 (10.95%)

BBSI

Barrett Business

$91.36

1.45 (1.61%)

BNGO

Bionano Genomics

$1.01

0.018 (1.81%)

IRMD

iRadimed

$25.77

1.87 (7.82%)

FC

Franklin Covey

$35.78

-0.27 (-0.75%)

NBEV

New Age Beverages

$1.92

0.06 (3.23%)

WATT

Energous

$1.99

0.04 (2.05%)

EAST

Eastside Distilling

$2.91

-0.02 (-0.68%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.25

1.47 (2.89%)

CLAR

Clarus

$13.49

0.59 (4.57%)

JRSH

Jerash Holdings

$6.46

-0.04 (-0.62%)

MCHX

Marchex

$3.65

-0.02 (-0.54%)

JYNT

Joint Corp.

$17.09

-0.42 (-2.40%)

SOLY

Soliton

$10.36

-0.045 (-0.43%)

SMSI

Smith Micro

$4.57

0.145 (3.28%)

PWFL

PowerFleet

$6.05

0.12 (2.02%)

OSIS

OSI Systems

$99.97

0.2 (0.20%)

LOVE

Lovesac

$11.81

-2.68 (-18.50%)

VERI

Veritone

$2.83

0.06 (2.17%)

WTER

Alkaline Water

$1.10

-0.02 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

RYAAY

Ryanair

$84.33

-0.15 (-0.18%)

04:54
12/13/19
12/13
04:54
12/13/19
04:54
Upgrade
Ryanair rating change  »

Ryanair upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAGY

IAG

$0.00

(0.00%)

04:54
12/13/19
12/13
04:54
12/13/19
04:54
Upgrade
IAG rating change  »

IAG upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:40
12/13/19
12/13
04:40
12/13/19
04:40
General news
FX Action: The yen has traded lower »

FX Action: The yen has…

03:55
12/13/19
12/13
03:55
12/13/19
03:55
General news
FX Action: USD-CAD dropped to a near six-week low »

FX Action: USD-CAD…

01:50
12/13/19
12/13
01:50
12/13/19
01:50
General news
Asian Market Update: »

Asian Market Update:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.